Total Payments
$926.21
2024 Payments
$240.55
Companies
10
Transactions
26
Medicare Patients
1,315
Medicare Billing
$90,913
Payment Breakdown by Category
Food & Beverage$926.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $926.21 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $391.83 | 9 | $0 (2024) |
| Horizon Therapeutics plc | $141.06 | 2 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $125.14 | 2 | $0 (2024) |
| Oyster Point Pharma, Inc. | $98.49 | 5 | $0 (2024) |
| Allergan, Inc. | $38.09 | 2 | $0 (2022) |
| Kala Pharmaceuticals, Inc. | $37.02 | 2 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $27.19 | 1 | $0 (2019) |
| RxSight Inc | $24.67 | 1 | $0 (2024) |
| ABBVIE INC. | $24.05 | 1 | $0 (2022) |
| Amgen Inc. | $18.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.55 | 8 | Tarsus Pharmaceuticals, Inc. ($125.14) |
| 2023 | $328.66 | 6 | Sun Pharmaceutical Industries Inc. ($187.60) |
| 2022 | $123.34 | 6 | Oyster Point Pharma, Inc. ($41.77) |
| 2021 | $61.08 | 3 | SUN PHARMACEUTICAL INDUSTRIES INC. ($39.65) |
| 2019 | $27.19 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($27.19) |
| 2018 | $19.54 | 1 | Allergan Inc. ($19.54) |
| 2017 | $125.85 | 1 | Sun Pharmaceutical Industries Inc. ($125.85) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $100.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Dry eyes | ||||||
| 04/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Dry eyes | ||||||
| 02/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Ophthalmology | ||||||
| 01/29/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, RXSIGHT INJECTOR CARTRIDGE | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/26/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Dry eyes | ||||||
| 08/10/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Ophthalmology | ||||||
| 05/04/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Ophthalmology | ||||||
| 04/12/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: TEPEZZA | ||||||
| 04/11/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $111.01 | General |
| Category: Ophthalmology | ||||||
| 03/22/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: TEPEZZA | ||||||
| 02/15/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Ophthalmology | ||||||
| 10/20/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DRY EYE | ||||||
| 07/18/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/07/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: DRY EYE | ||||||
| 03/31/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Ophthalmology | ||||||
| 03/31/2022 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Ocular | ||||||
| 02/01/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Ophthalmology | ||||||
| 06/17/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Ophthalmology | ||||||
| 03/18/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Ocular | ||||||
| 11/26/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/10/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 314 | 366 | $50,120 | $22,784 |
| 2022 | 7 | 347 | 386 | $44,242 | $23,317 |
| 2021 | 7 | 338 | 379 | $38,006 | $23,624 |
| 2020 | 4 | 316 | 351 | $34,810 | $21,189 |
Total Patients
1,315
Total Services
1,482
Medicare Billing
$90,913
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 149 | 167 | $29,225 | $13,112 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 91 | $10,010 | $5,551 | 55.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 17 | 17 | $3,400 | $1,465 | 43.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 31 | 33 | $2,805 | $1,066 | 38.0% |
| 92134 | Imaging of retina | Office | 2023 | 30 | 33 | $2,805 | $1,003 | 35.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 25 | 25 | $1,875 | $586.95 | 31.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 152 | 159 | $23,939 | $12,428 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 90 | $8,378 | $5,431 | 64.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 40 | 41 | $3,217 | $1,730 | 53.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 20 | 20 | $2,067 | $1,054 | 51.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 12 | 12 | $2,264 | $1,031 | 45.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 34 | 37 | $2,507 | $973.46 | 38.8% |
| 92134 | Imaging of retina | Office | 2022 | 24 | 27 | $1,870 | $668.97 | 35.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 178 | 192 | $23,936 | $15,371 | 64.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 35 | 36 | $3,198 | $2,300 | 71.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 29 | $2,595 | $1,919 | 74.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 36 | 42 | $2,656 | $1,711 | 64.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 22 | $1,225 | $871.01 | 71.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 23 | 27 | $2,101 | $749.39 | 35.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 29 | 31 | $2,295 | $702.97 | 30.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 179 | 184 | $22,960 | $14,266 | 62.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 79 | $5,795 | $3,915 | 67.6% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 41 | 47 | $2,991 | $2,077 | 69.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 37 | 41 | $3,064 | $929.97 | 30.4% |
About Dr. Nina Gelfond, OD
Dr. Nina Gelfond, OD is a Optometrist healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679568018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nina Gelfond, OD has received a total of $926.21 in payments from pharmaceutical and medical device companies, with $240.55 received in 2024. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($926.21).
As a Medicare-enrolled provider, Gelfond has provided services to 1,315 Medicare beneficiaries, totaling 1,482 services with total Medicare billing of $90,913. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Buffalo, NY
- Active Since 09/12/2005
- Last Updated 10/19/2015
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1679568018
Products in Payments
- Cequa (Drug) $265.98
- TEPEZZA (Drug) $141.06
- Bromsite (Drug) $125.85
- XDEMVY (Drug) $125.14
- TYRVAYA (Drug) $98.49
- VUITY (Drug) $42.60
- INVELTYS (Drug) $37.02
- BIOTRUE ONE DAY (Device) $27.19
- RXSIGHT CONTACT LENS (Device) $24.67
- LUMIGAN (Drug) $19.54
- TEPEZZA (Biological) $18.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Buffalo
Dr. David Burstein, Od, OD
Optometrist — Payments: $4,691
Optometrist $4,691
Dr. Calogera Mendola, Od, OD
Optometrist — Payments: $2,663
Optometrist $2,663
Dr. Paul Pronti
Optometrist — Payments: $2,474
Optometrist $2,474
James Mcdonel, O.d, O.D
Optometrist — Payments: $2,365
Optometrist $2,365
Melina Perez, Od, OD
Optometrist — Payments: $2,364
Optometrist $2,364
Dr. Mark Sorrentino, O.d, O.D
Optometrist — Payments: $2,215
Optometrist $2,215